
iBio, Inc.
IBIOHealthcare|Biotechnology|US
$0.74
+0.01 (+1.16%)
DCF Value
$0.49
Tangible Book / Share
$0.81
Cash / Share
$0.85
Next Earnings Report
Nov 11, 2026
EPS est. -$0.07 · Revenue est. $25.0K
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Apr 29, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (1)
May 2027
Est. completion
P1Overweight , Obesity
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults
NCT07487376n=32
Recent Press Releases
iBio to Participate in Upcoming Investor Conferences
Nov 2, 2026 · GlobeNewsWire
iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610's Potential to Preserve Muscle in Combination with GLP-1 Therapy
Oct 13, 2026 · GlobeNewsWire
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
Sep 1, 2026 · GlobeNewsWire
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
Aug 28, 2026 · GlobeNewsWire
SEC Filings (112)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 19, 2026 | 8-K | Material event | DocumentIndex |
| Oct 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 13, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Sep 4, 2026 | ARS | Annual report to holders | DocumentIndex |
| Sep 4, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 28, 2026 | 10-K | Annual report | DocumentIndex |
| Aug 28, 2026 | 8-K | Material event | DocumentIndex |
| Aug 20, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 4, 2026 | 8-K | Material event | DocumentIndex |
| Jul 17, 2026 | 8-K | Material event | DocumentIndex |
| Jul 1, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| May 8, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 17, 2026 | 8-K/A | Material event | DocumentIndex |
| Apr 8, 2026 | 8-K | Material event | DocumentIndex |
| Mar 9, 2026 | 8-K | Material event | DocumentIndex |
| Mar 6, 2026 | EFFECT | DocumentIndex | |
| Mar 6, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Feb 27, 2026 | 8-K | Material event | DocumentIndex |
| Feb 27, 2026 | S-3 | Shelf registration | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 10, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Feb 10, 2026 | 8-K | Material event | DocumentIndex |
| Feb 9, 2026 | EFFECT | DocumentIndex |